(Reuters) – U.S. pharma giant Pfizer Inc is planning to pull back on early-stage research into treatments for rare diseases, including development of new viral-based gene therapies, financial newspaper Barron’s said on Thursday.
(Reporting by Shubhendu Deshmukh in Bengaluru; Editing by Sherry Jacob-Phillips)
